Table 2 Antimicrobial susceptibility rates for Gram-negative bacteria
Gram-negative bacteria | S | I | R | %S |
|---|---|---|---|---|
Amikacin | 28 | 0 | 17 | 62% |
Ampicillin/sulbactam | 1 | 0 | 0 | 0% |
Amoxacillin-clavulanic acid | 5 | 0 | 28 | 15% |
Ceftazidime-avibactam | 32 | 0 | 5 | 86% |
Ceftolozane-tazobactam | 22 | 0 | 15 | 59% |
Ciprofloxacin | 16 | 5 | 17 | 45% |
Gentamicin | 20 | 0 | 23 | 47% |
Imipenem | 26 | 0 | 18 | 58% |
Levofloxacin | 17 | 0 | 27 | 73% |
Meropenem | 30 | 0 | 18 | 62% |
Meropenem-vaborbactam | 33 | 0 | 0 | 100% |
Piperacillin-tazobactam | 10 | 0 | 27 | 27% |
Trimethoprim-sulfamethoxazole | 8 | 0 | 36 | 82% |
Tobramycin | 19 | 0 | 28 | 40% |
Temocillin | 0 | 13 | 17 | 0% |
Ampicillin | 5 | 0 | 28 | 15% |
Aztreonam | 12 | 0 | 21 | 36% |
Cefepime | 12 | 5 | 20 | 32% |
Cefotaxime | 1 | 0 | 0 | 0% |
Ceftazidime | 12 | 4 | 21 | 32% |
Ceftriaxone | 12 | 0 | 21 | 36% |
Cefuroxime | 7 | 0 | 23 | 23% |
Ertapenem | 18 | 0 | 15 | 55% |
Colistin | 0 | 0 | 2 | 0% |
Totals | 346 | 27 | 427 | 43% |